Обалдеть! Молодцы, ну что ещё сказать можно!
This includes the work of EBSCO’s DynaMed outfit, which provides physicians with peer-reviewed clinical content, guidelines and scientific literature reviews across several specialties and disease topics.
IBM, meanwhile, will put up its Micromedex drug reference database, designed to support provider decision-making, toxicology analyses and therapy management. The objective is to furnish a single, point-of-care clinical decision support solution, dubbed “DynaMed and Micromedex with Watson.”https://www.fiercebiotech.com/medtech/ibm-watson-health-to-tap-ebsco-s-dynamed-libraries-for-a-combined-ai-drug-information-suite